X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://endpts.com/unfazed-by-os-flop-zai-lab-eyes-imminent-china-filing-for-macrogenics-her2-drug/
https://endpts.com/macrogenics-flips-over-an-os-dud-for-cancer-drug-margenza-in-surprising-turnaround-from-earlier-data/
https://www.globenewswire.com/news-release/2020/07/09/2060324/0/en/MacroGenics-Announces-Lancet-Oncology-Publication-of-Margetuximab-Data-in-Gastric-Cancer.html#:~:text=(NASDAQ%3A%20MGNX)%2C%20a,pembrolizumab%20as%20a%20chemotherapy%2Dfree
http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-announces-margetuximab-granted-orphan-drug
https://www.globenewswire.com/news-release/2020/05/28/2040109/0/en/MacroGenics-Provides-Update-on-FDA-Review-of-Margetuximab-for-HER2-Positive-Metastatic-Breast-Cancer.html
http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-announces-submission-margetuximab-biologics-license
https://www.fiercebiotech.com/biotech/sabcs-macrogenics-margetuximab-posts-os-gains-specific-metastatic-breast-cancer-patients
https://seekingalpha.com/news/3508121-macrogenics-margetuximab-shows-survival-benefit-late-stage-breast-cancer-study
https://seekingalpha.com/news/3508121-macrogenics-margetuximab-shows-survival-benefit-late-stage-breast-cancer-study
Market Place
Share 
